SCHEMBL2324889

SCHEMBL2324889

CC(O[Sn](C(F)(F)C(F)(F)C(F)(F)C(F)(F)F)(C(F)(F)C(F)(F)C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F)c1ccccc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 1/20 0.33
HCAR2 Q8TDS4 1/20 0.32
ADRA2C P18825 3/20 0.32
ADRA2A P08913 2/20 0.32
KDM4E B2RXH2 2/20 0.32
LMNA P02545 1/20 0.32
HIF1A Q16665 1/20 0.32
KMT2A Q03164 2/20 0.31
MEN1 O00255 1/20 0.31
SLC6A4 P31645 1/20 0.31
ALDH1A1 P00352 2/20 0.31
ADRA2B P18089 1/20 0.30
TAAR1 Q96RJ0 1/20 0.30
CHRM2 P08172 1/20 0.30
ADRA1A P35348 1/20 0.30
AOC3 Q16853 1/20 0.30
RGS12 O14924 1/20 0.30
GLA P06280 1/20 0.30
CYP3A4 P08684 1/20 0.30
CYP2D6 P10635 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2344674 0.84 SLC6A4 (0.33) TACR1HCAR2ADRA2CADRA2AKDM4E
SCHEMBL2339084 0.68 TACR1 (0.32) TACR1TAAR1
SCHEMBL2341570 0.68 TACR1 (0.34) TACR1HCAR2ALDH1A1TSHR
SCHEMBL2321905 0.68 HCAR2 (0.33) TACR1HCAR2ADRA2CADRA2AKDM4E
SCHEMBL2330109 0.68 HCAR2 (0.40) HCAR2ADRA2CADRA2AKDM4ELMNA
SCHEMBL2697119 0.68 HCAR2 (0.40) HCAR2ADRA2CADRA2AKDM4ELMNA
SCHEMBL7851156 0.66 TACR1 (0.39) TACR1HCAR2ADRA2CADRA2AKDM4E
SCHEMBL20002096 0.66 RIPK1 (0.37) TACR1HCAR2ADRA2CADRA2AKMT2A
SCHEMBL2323305 0.66 LMNA (0.35) TACR1HCAR2LMNAKMT2AMEN1
SCHEMBL2325875 0.66 TSHR (0.39) KDM4ELMNAHIF1AKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1987881-B1 METHOD FOR SEPARATION AND COLLECTION OF DIALKYL TIN DIALKOXIDE ASAHI KASEI CHEMICALS CORP (JP) 2011-08-17 EP disclosed
US-7842828-B2 Method for separating out and recovering dialkyltin dialkoxide ASAHI KASEI CHEMICALS CORPORATION (JP) 2010-11-30 US disclosed
US-20100160662-A1 Method for Separating Out and Recovering Dialkyltin Dialkoxide ASAHI KASEI KABUSHIKI KAISHA (JP) 2010-06-24 US disclosed
EP-1987881-A1 METHOD FOR SEPARATION AND COLLECTION OF DIALKYL TIN DIALKOXIDE Asahi Kasei Chemicals Corporation (JP) 2008-11-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160662-A1 Method for Separating Out and Recovering Dialkyltin Dialkoxide ALOX5, ALOX15B, ALOX15 TACR1 2330/4885HCAR2 861/4885ADRA2C 3277/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.